l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with ketotifen in 2 studies
| Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (ketotifen) | Trials (ketotifen) | Recent Studies (post-2010) (ketotifen) |
|---|---|---|---|---|---|
| 138 | 7 | 2 | 1,212 | 275 | 151 |
| Protein | Taxonomy | l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50) | ketotifen (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.16 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.838 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.009 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.374 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.187 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.112 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.71 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.537 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 2.209 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.872 | |
| Histamine H2 receptor | Homo sapiens (human) | 4.129 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.727 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.031 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.16 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.537 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0011 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.963 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.046 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.141 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guth, PH; Király, A; Süto, G; Taché, Y | 1 |
| Adelson, D; Akiba, Y; Engel, E; Guth, PH; Kaunitz, JD; Kawakubo, K; Taché, Y | 1 |
2 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and ketotifen
| Article | Year |
|---|---|
Ketotifen prevents gastric hyperemia induced by intracisternal thyrotropin-releasing hormone at a low dose.
Topics: Animals; Blood Pressure; Cisterna Magna; Gastric Acid; Gastric Mucosa; Hyperemia; Injections; Ketotifen; Male; Mast Cells; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Thyrotropin-Releasing Hormone; Vascular Resistance | 1997 |
Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats.
Topics: Animals; Blood Pressure; Cell Count; Cell Degranulation; Connective Tissue Cells; Cromolyn Sodium; Dose-Response Relationship, Drug; Gastric Mucosa; Histamine Antagonists; Hyperemia; Injections, Intraventricular; Ketotifen; Male; Mast Cells; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Serotonin Antagonists; Stomach; Thioxanthenes; Thyrotropin-Releasing Hormone; Vascular Resistance; Xanthones | 2005 |